喹硫平或奥氮平联合丙戊酸钠缓释片治疗维族双相障碍精神病的疗效研究

Effect of quetiapine or olanzapine combined with sodium valproate on treatment of Uighur patients with bipolar disorder

目的探讨喹硫平、奥氮平联合丙戊酸钠缓释片对维族双相障碍精神病临床疗效的影响。方法选择2015年6月—2016年6月在乌鲁木齐市第四人民医院治疗双相障碍精神病的患者100例,随机分为2组,每组50例,对照组患者服用奥氮平联合丙戊酸钠缓释片,观察组患者服用喹硫平联合丙戊酸钠缓释片,服药1、4、8周时患者于医院进行复查,填写17项HMDM评分表、BRMD评分表以及GSI-IS评分表评估两组患者在不同时间的抑郁、躁狂情况和临床疗效。结果两组患者在治疗期间,临床症状减轻,治疗1、4、8周时HMDM评分、BRMD评分以及GSI-IS评分均显著低于治疗前(P<0.05),且随疗程的延长,症状趋于减轻甚至消失;观察组各量表评分比对照组低,但是统计学分析无显著差异。记录两组患者治疗过程中发生不良反应的情况,结果显示观察组患者不良反应的总发生率和头晕嗜睡的发生率较对照组明显降低(P<0.05)。结论奥氮平或喹硫平联合丙戊酸钠缓释片可以有效控制维族双相障碍患者抑郁、躁狂症状,且奥氮平联合丙戊酸钠缓释片可以显著降低不良反应发生率,值得临床推广应用。

Objective To explore the effect of quetiapine or olanzapine combined with sodium valproate on curative for Uighur patients with bipolar disorder.Methods Totally 100 Uighur patients with bipolar disorder were enrolled in The Fourth People＆#39;s Hospital of Urumqi from June 2015 to June 2016,of which patients divided into two groups randomly,the patients of control group （n =50） accepted sodium valproate combined with olanzapine,and patients in observation group （n =50） were administered with sodium valproate combined with quetiapine.The patients taking medicine were reviewed at the hospital after 1,4,and 8 weeks,and the depression and manic state and severity of clinical efficacy with 17 HMDM score,BRMD score and GSI-IS score questionnaire were evaluated.Results Each score of questionnaire was significantly lower than that before treatment （P 〈 0.05）,all patients＆#39;clinical symptoms were relieved obviously,and symptoms tended to reduce or even disappeared with the extension of the course of treatment.Each score of questionnaire in observation group was lower than that in control group,bur difference has no statistical significance;Comparing the incidence of adverse reaction of two groups,the patients with dizziness and sleepiness in observation group were significantly decreased compared with observation group （P 〈 0.05）.Conclusions Quetiapine or olanzapine combined with sodium valproate for Uighur patients with bipolar disorder deserved popularization in clinic as the efficacious remission of depression and manic state.